Lobe-specific lymph node sampling is associated with lower risk of cancer recurrenceCentral MessagePerspective by Melanie P. Subramanian, MD, MPHS, Daniel B. Eaton, Jr., MPH, Brendan T. Heiden, MD, MPHS, Whitney S. Brandt, MD, Ulysses L. Labilles, PhD, Su-Hsin Chang, PhD, SM, Yan Yan, MD, PhD, Martin W. Schoen, MD, MPHS, Mayank R. Patel, MD, Daniel Kreisel, MD, PhD, Ruben G. Nava, MD, Theodore Thomas, MD, MPH, Bryan F. Meyers, MD, MPH, Benjamin D. Kozower, MD, MPHS, Varun Puri, MD, MSCI

Get full text